Clinical application of blood biomarkers in cerebrovascular disease.

Published

Journal Article (Review)

Identifying a biomarker or panel of biomarkers of cerebral ischemia would have a major impact on the care of stroke patients by facilitating early management decisions and individualization of care. Biochemical surrogates of cerebral ischemia might also play an important role by identifying relevant pathways for novel therapeutic strategies and by facilitating early clinical trials in cerebrovascular disease. Serum biomarkers related to pathways of hemostasis, oxidation and inflammation, or alterations in glial and neuronal proteins, have been identified but none have been recommended for routine clinical use. This review describes the most promising biomarkers of cerebrovascular disease and the context and limitations in which they have been studied.

Full Text

Duke Authors

Cited Authors

  • El Husseini, N; Laskowitz, DT

Published Date

  • February 2010

Published In

Volume / Issue

  • 10 / 2

Start / End Page

  • 189 - 203

PubMed ID

  • 20136376

Pubmed Central ID

  • 20136376

Electronic International Standard Serial Number (EISSN)

  • 1744-8360

Digital Object Identifier (DOI)

  • 10.1586/ern.09.151

Language

  • eng

Conference Location

  • England